tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market
Advertisement

Biosyent (RX) Ratios

Compare
48 Followers

Biosyent Ratios

TSE:RX's free cash flow for Q1 2025 was C$0.76. For the 2025 fiscal year, TSE:RX's free cash flow was decreased by C$ and operating cash flow was C$0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.90 6.48 6.49 8.24 5.79
Quick Ratio
4.00 5.42 5.70 7.70 5.39
Cash Ratio
1.87 1.44 1.38 4.36 3.95
Solvency Ratio
1.26 1.02 0.83 1.20 0.64
Operating Cash Flow Ratio
1.20 0.91 0.87 1.13 1.34
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
C$ 21.89MC$ 29.10MC$ 30.02MC$ 28.47MC$ 23.00M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.03 0.04 0.05
Debt-to-Equity Ratio
0.03 0.04 0.04 0.05 0.06
Debt-to-Capital Ratio
0.03 0.03 0.04 0.05 0.06
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.19 1.19 1.21 1.18 1.25
Debt Service Coverage Ratio
151.14 102.09 77.60 80.05 47.33
Interest Coverage Ratio
170.38 109.21 90.51 96.00 54.12
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.09 0.11 0.12 0.13 0.14
Net Debt to EBITDA
-0.88 -0.75 -0.81 -1.85 -3.18
Profitability Margins
Gross Profit Margin
78.51%81.03%81.85%79.10%78.02%
EBIT Margin
27.66%27.23%25.00%28.59%22.52%
EBITDA Margin
29.46%28.67%28.50%31.17%26.15%
Operating Profit Margin
25.22%23.65%25.00%28.59%22.52%
Pretax Profit Margin
27.52%27.01%26.61%29.28%23.45%
Net Profit Margin
20.43%20.45%19.55%21.95%16.99%
Continuous Operations Profit Margin
20.43%20.45%19.55%21.95%16.99%
Net Income Per EBT
74.26%75.70%73.46%74.97%72.47%
EBT Per EBIT
109.10%114.22%106.43%102.39%104.11%
Return on Assets (ROA)
18.29%15.56%13.48%16.90%11.31%
Return on Equity (ROE)
21.76%18.59%16.36%19.91%14.16%
Return on Capital Employed (ROCE)
26.15%20.76%20.08%24.77%17.69%
Return on Invested Capital (ROIC)
19.32%15.63%14.68%18.48%12.75%
Return on Tangible Assets
20.69%16.00%13.89%17.31%11.66%
Earnings Yield
5.88%6.04%6.34%5.99%3.69%
Efficiency Ratios
Receivables Turnover
6.99 8.91 8.78 11.47 12.30
Payables Turnover
1.73 1.18 1.00 1.68 1.32
Inventory Turnover
1.56 1.02 1.12 2.71 2.37
Fixed Asset Turnover
33.17 21.94 16.69 14.82 10.33
Asset Turnover
0.90 0.76 0.69 0.77 0.67
Working Capital Turnover Ratio
1.83 1.02 0.91 1.05 0.93
Cash Conversion Cycle
75.36 90.73 3.57 -51.12 -93.03
Days of Sales Outstanding
52.24 40.98 41.57 31.81 29.66
Days of Inventory Outstanding
234.14 359.04 326.68 134.54 154.20
Days of Payables Outstanding
211.02 309.29 364.68 217.47 276.89
Operating Cycle
286.38 400.02 368.26 166.35 183.86
Cash Flow Ratios
Operating Cash Flow Per Share
0.62 0.42 0.40 0.37 0.53
Free Cash Flow Per Share
0.19 0.41 0.36 0.36 0.52
CapEx Per Share
0.43 0.01 0.04 <0.01 0.01
Free Cash Flow to Operating Cash Flow
0.31 0.97 0.90 0.98 0.97
Dividend Paid and CapEx Coverage Ratio
1.01 2.42 4.93 50.17 39.56
Capital Expenditure Coverage Ratio
1.45 29.01 9.53 50.17 39.56
Operating Cash Flow Coverage Ratio
7.06 4.14 3.55 3.00 4.03
Operating Cash Flow to Sales Ratio
0.18 0.16 0.18 0.16 0.31
Free Cash Flow Yield
1.61%4.56%5.14%4.37%6.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.00 16.56 15.78 16.69 27.09
Price-to-Sales (P/S) Ratio
3.54 3.39 3.08 3.66 4.60
Price-to-Book (P/B) Ratio
3.69 3.08 2.58 3.32 3.84
Price-to-Free Cash Flow (P/FCF) Ratio
62.27 21.91 19.44 22.88 15.30
Price-to-Operating Cash Flow Ratio
19.03 21.16 17.40 22.42 14.91
Price-to-Earnings Growth (PEG) Ratio
1.79 0.73 -1.31 0.23 -4.20
Price-to-Fair Value
3.69 3.08 2.58 3.32 3.84
Enterprise Value Multiple
11.12 11.06 10.01 9.90 14.42
Enterprise Value
125.40M 100.19M 79.65M 88.33M 84.23M
EV to EBITDA
11.12 11.06 10.01 9.90 14.42
EV to Sales
3.28 3.17 2.85 3.09 3.77
EV to Free Cash Flow
57.69 20.53 17.98 19.28 12.53
EV to Operating Cash Flow
17.94 19.82 16.10 18.90 12.22
Tangible Book Value Per Share
2.75 2.81 2.61 2.42 1.98
Shareholders’ Equity Per Share
3.20 2.91 2.71 2.49 2.06
Tax and Other Ratios
Effective Tax Rate
0.26 0.24 0.27 0.25 0.28
Revenue Per Share
3.40 2.64 2.27 2.26 1.72
Net Income Per Share
0.69 0.54 0.44 0.50 0.29
Tax Burden
0.74 0.76 0.73 0.75 0.72
Interest Burden
0.99 0.99 1.06 1.02 1.04
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
0.29 0.31 0.32 0.16 0.18
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.01
Income Quality
0.89 0.78 0.91 0.74 1.82
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis